ContractPodAi is now LeahGet a Demo

Why a Swiss Biotech Company Selected Leah for Pharmaceutical Contract Management

A Swiss pharmaceutical/biotechnology company conducting clinical research studies across the United States, Switzerland, Germany, France, and the United Kingdom faced a contract management challenge common to emerging biotech organizations. With approximately 1,000 active contracts spanning research collaborations, clinical trial agreements, consulting relationships, and vendor partnerships, their small legal team needed a centralized solution that could meet stringent pharmaceutical regulatory requirements without overwhelming their limited resources.

Why a Swiss Biotech Company Selected Leah for Pharmaceutical Contract Management
Challenges
1,000

Active contracts requiring centralized management across R&D, clinical operations, and manufacturing

10 years

Data retention requirements mandated by FDA/EMA pharmaceutical regulations

3 people

Lean legal team managing contracts across Medical Sciences, Clinical Sciences, Clinical Operations, Regulatory Affairs, and IP functions

“We needed a solution that could handle pharmaceutical regulatory requirements while remaining manageable for our small team. Contract visibility and compliance documentation were almost nonexistent.”

Executive Manager of Procurement, Swiss Biotech Company

Challenge

A Swiss pharmaceutical/biotechnology company conducting clinical research studies across the United States, Switzerland, Germany, France, and the United Kingdom faced a contract management challenge common to emerging biotech organizations. With approximately 1,000 active contracts spanning research collaborations, clinical trial agreements, consulting relationships, and vendor partnerships, their small legal team needed a centralized solution that could meet stringent pharmaceutical regulatory requirements without overwhelming their limited resources.

The company operates in a heavily regulated environment subject to FDA and EMA oversight, requiring strict compliance with GXP standards, 10-year data retention mandates, and comprehensive audit trail documentation for all contract-related activities. Managing contracts across distributed teams—from CMC (Chemistry, Manufacturing, and Controls) to Medical Sciences to Clinical Operations—created visibility gaps and compliance risks. The team lacked centralized repository capabilities, struggled with manual contract execution processes, and had no systematic approach to tracking renewal obligations and critical dates.

The organization's contract portfolio heavily weighted toward confidentiality agreements and CDAs—typical for pharmaceutical research partnerships—along with consulting agreements supporting clinical development programs, statements of work, and clinical trial agreements. With contract activity spanning multiple geographies and therapeutic areas, the legal team needed better tools to maintain consistent contract language, track obligations, and provide audit-ready documentation.

For a lean legal team managing this volume and complexity, the status quo created operational inefficiencies and compliance exposure that would only worsen as the company scaled its clinical development programs.

Solution Search

The pharmaceutical company began evaluating contract lifecycle management platforms with a clear set of requirements shaped by their regulatory environment and organizational constraints. Unlike larger pharmaceutical companies with extensive legal departments, they needed a solution that delivered foundational CLM capabilities without requiring heavy implementation resources or complex workflow orchestration that would exceed their capacity to manage.

Regulatory compliance capabilities were non-negotiable. Any solution needed to provide comprehensive audit trails meeting pharmaceutical industry standards, including detailed logging of user access, contract modifications, and system activities. The platform needed to support 10-year data retention requirements and generate audit-ready documentation for FDA, EMA, and other regulatory inspections. GXP compliance oversight and security standards had to align with their quality assurance team's validation requirements.

The team also prioritized practical operational needs: centralized repository functionality for contract search and retrieval, electronic signature integration to streamline execution workflows, automated renewal and obligation reminders to reduce compliance risk, template management for high-volume contract types like CDAs and consulting agreements, and user management with governance controls appropriate for a small, distributed team.

Cost-effectiveness factored heavily in their evaluation. As an emerging biotech company, they needed to justify technology investments against contract volumes and legal team capacity. They weren't looking for the most sophisticated platform on the market—they needed right-sized capabilities that would deliver value without over-investment in features they wouldn't fully utilize.

Scalability mattered, but within reason. The solution needed to accommodate their current ~1,000 contract portfolio and support modest growth as clinical programs advanced, but they weren't planning for enterprise-scale deployments requiring hundreds of users or complex workflow automation across business units.

The evaluation process revealed that many CLM platforms were either too basic (lacking pharmaceutical compliance capabilities) or too complex (requiring implementation resources and feature sophistication beyond their needs). They needed a vendor who understood pharmaceutical regulatory requirements while offering flexible deployment that matched their team's capacity and contract management maturity.

“We needed to be realistic about what we would actually use versus what looked impressive in demonstrations. For our contract volume, sophisticated capabilities needed to justify their cost.”

Contract Operations Lead, Swiss Biotech Company

Why Leah

Leah’s contract lifecycle management platform aligned with the pharmaceutical company's core requirements while offering flexibility to grow capabilities over time. Several factors drove their selection decision.

Pharmaceutical-Ready Compliance Capabilities: The platform provided audit trail functionality designed for regulated industries, supporting the comprehensive logging and documentation requirements essential for FDA and EMA compliance. The system's ability to maintain detailed records of contract workflows, user access, and modifications gave their quality assurance team confidence that the solution could meet pharmaceutical validation standards. Built-in support for 10-year data retention aligned with industry regulatory requirements without requiring custom configuration.

Foundational CLM Without Complexity: Leah offered robust repository capabilities, DocuSign integration for electronic signatures, automated renewal reminders, and template management—the core functionality their small legal team needed—without forcing them into complex workflow automation they weren't ready to implement. This "right-sized" approach meant they could deploy foundational capabilities quickly and expand functionality as their contract management maturity evolved.

Template Flexibility for High-Volume Contract Types: The platform's template library and workflow capabilities offered a clear path to automate their highest-volume contract types, particularly the confidentiality agreements and CDAs that represented the bulk of their processing. While they planned to start with manual uploads during implementation, the template infrastructure was ready when they were prepared to transition to more automated authoring workflows.

Responsive Partnership Approach: Throughout the evaluation process, the Leah team demonstrated responsiveness to their specific pharmaceutical use cases and regulatory questions. The vendor's willingness to discuss compliance requirements in detail and provide guidance on pharmaceutical industry best practices built confidence that this would be a true partnership rather than a transactional software relationship.

Competitive Platform Positioning for Future Growth: When the team later evaluated Leah’s platform for advanced capabilities like AI-powered redlining and automated metadata extraction, they found the offering represented strong value compared to other CLM competitors in the market. While they ultimately chose not to expand into AI features due to cost-benefit considerations for their contract volume, the competitive strength of the platform's roadmap gave them confidence they had selected a vendor positioned for long-term innovation.

"Leah provided the foundational CLM capabilities we needed for pharmaceutical compliance while maintaining flexibility. We weren't forced into complexity we couldn't manage, but the platform could grow with us."

— Senior Director Legal, Swiss Biotech Company

The decision reflected pragmatic technology investment discipline: choosing a vendor who could meet their immediate regulatory and operational needs while offering a credible path for capability expansion if their contract volumes and organizational requirements evolved. For a small pharmaceutical legal team managing complex compliance obligations, Leah offered the right balance of pharmaceutical-ready functionality, implementation manageability, and partnership responsiveness.

With Leah’s CLM platform, the legal team was positioned to centralize their contract repository, streamline execution workflows, and maintain the audit-ready documentation their regulated environment demanded—all while preserving the flexibility to expand capabilities as their clinical development programs and contract management needs matured.

Ready to transform your legal operations?

See What Leah Can Do